MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
1.410
-0.070 (-4.73%)
At close: Mar 20, 2026, 4:00 PM EDT
1.394
-0.016 (-1.17%)
After-hours: Mar 20, 2026, 7:57 PM EDT
MetaVia Market Cap
MetaVia has a market cap or net worth of $294.82 thousand as of March 20, 2026. Its market cap has decreased by -97.82% in one year.
Market Cap
294.82K
Enterprise Value
-13.91M
1-Year Change
-97.82%
Ranking
Category
Stock Price
$1.41
Market Cap Chart
Since December 31, 2019, MetaVia's market cap has decreased from $104.41B to $294.82K, a decrease of -100.00%. That is a compound annual growth rate of -87.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 4.52M | -75.59% |
| Dec 31, 2025 | 18.54M | 5.97% |
| Dec 31, 2024 | 17.49M | -2.47% |
| Dec 29, 2023 | 17.93M | 31.75% |
| Dec 30, 2022 | 13.61M | -58.04% |
| Dec 31, 2021 | 32.44M | -62.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KALA BIO | 1.94M |
| Propanc Biopharma | 1.79M |
| Dermata Therapeutics | 1.72M |
| Jaguar Health | 1.57M |
| CNS Pharmaceuticals | 1.42M |
| Clearmind Medicine | 989.89K |
| OKYO Pharma | 903.87K |
| CDT Equity | 793.03K |